logo

For the Inventor, By the Inventor

Fukushima, Japan

Yukio Sato

This inventor holds 3 USPTO granted patents. Top assignees: Taisho Pharmaceutical Co., Ltd., Cadix Inc., Other. Active years: 1988-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yukio Sato. Retrieved from https://idiyas.com/inventor/yukio-sato-zuengbso

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

% Patents Active = 66.7

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 243(Granted Patents)


Location History:

  • 2-2-8,Wakamizu, Chikusa-ku, Nagoya-shi, JP (1988)
  • Fukushima-shi, JP (2000)
  • Fukushima-shi, Fukushima JP (2011)

Company Filing History:

goldMedal2 out of 314 
 
Taisho Pharmaceutical Co., Ltd.
 patents
silverMedal1 out of 8 
 
Cadix Inc.
 patents
bronzeMedal3 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1988-2011

Loading Chart...
3 patents (USPTO):Explore Patents
1. 7871984 - Methylated CpG polynucleotide (2011-01-18),
2. 6090791 - Method for inducing mucosal immunity (2000-07-18),
3. 4794262 - Method and apparatus for measuring profile of three-dimensional object (1988-12-27),

Title: Innovations of Yukio Sato

Introduction

Yukio Sato is a notable inventor based in Fukushima, Japan. He has made significant contributions to the field of immunology through his innovative patents. With a total of 3 patents, Sato's work focuses on enhancing immune responses and developing therapeutic solutions for immune-mediated diseases.

Latest Patents

One of Sato's latest patents is related to a methylated CpG polynucleotide. This invention aims to provide a polynucleotide that effectively suppresses immunoreactivity caused by DNA with a CpG motif. It has potential applications in preventing and treating immune-mediated diseases such as arthritis. Another significant patent is a method for inducing mucosal immunity. This method involves injecting plasmid DNAs or oligonucleotides containing a specific DNA sequence into mammalian mucosal cells, which can induce mucosal immunity and promote the production of CD4 positive T cells capable of generating interleukin 10 and IFN-γ.

Career Highlights

Throughout his career, Yukio Sato has worked with various organizations, including Taisho Pharmaceutical Co., Ltd. His research and inventions have contributed to advancements in immunology and therapeutic development.

Collaborations

Sato has collaborated with notable colleagues such as Atsushi Irisawa and Hiroko Kobayashi. Their joint efforts have furthered research in the field and led to innovative solutions in immunotherapy.

Conclusion

Yukio Sato's contributions to immunology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of immune-mediated diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…